Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05428176 · ClinicalTrials.gov registry record · NA
A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors
A NA study of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia, sponsored by City of Hope Medical Center.
- Active
- Registry status
- NA
- Development phase
- 342
- Enrollment target
- 4
- Study locations
NCT05428176 is a NA study of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 342 participants, above the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (197% higher). The trial reports 4 study locations across 1 state.
The verdict
NCT05428176, a NA study of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia, is active but no longer recruiting, sponsored by City of Hope Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 342 participants
- Enrollment target
- 4
- Study locations
Study Summary
This clinical trial evaluates a high intensity electronic health (eHealth) intervention program for reducing learning disparities in children with cancer. Most children with leukemia and lymphoblastic lymphoma can be cured due to advancements in diagnosis and treatment. However, because treatments for these conditions target the central nervous system, these children are at increased risk for developing neurocognitive late effects (problems with attention, thinking, learning, and remembering). Fortunately, many survivors do well, but some children continue to struggle with learning and have academic difficulties after their cancer treatments. The purpose of this research study is to see whether providing parents with educational knowledge and parenting tips using videoconferencing and a special website better helps their cancer survivor child in learning and school achievement compared to typical services.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Best Practice
- OTHER Internet-Based Intervention
Study Locations (4)
California
- City of Hope Medical Center - Duarte
- Childrens Hospital of Los Angeles - Los Angeles
- Rady Children's Hospital San Diego - San Diego
- University of Calif San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2023-02-16 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05428176
The ClinicalTrials.gov registry entry for NCT05428176 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 342 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (197% higher). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Acute Myeloid Leukemia appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT05428176 reports 4 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05428176 about?
NCT05428176 is a clinical study titled "A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors". This clinical trial evaluates a high intensity electronic health (eHealth) intervention program for reducing learning disparities in children with cancer. Most children with leukemia and lymphoblastic lymphoma can be cured due to advancements in diagnosis and treatment. However, because treatments f...
What is the current status of trial NCT05428176?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 342 participants. The study started on 2023-02-16. Estimated completion is 2027-06-30.
What conditions does trial NCT05428176 study?
This clinical trial studies the following conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Leukemia, Lymphoblastic Lymphoma.
What interventions are being tested in trial NCT05428176?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Best Practice (OTHER), Internet-Based Intervention (OTHER).
Who is sponsoring clinical trial NCT05428176?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05428176 being conducted?
This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myeloid Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
RECRUITING · NA
-
A Telehealth Advance Care Planning Intervention
RECRUITING · NA
-
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
RECRUITING · NA
-
Massage Impact on Sleep in Pediatric Oncology
RECRUITING · NA
-
Home Blood Transfusions
RECRUITING · NA
-
Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.